Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("RAVDIN, Peter")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 34

  • Page / 2
Export

Selection :

  • and

Docetaxel versus paclitaxel in the adjuvant setting : translating SABCS into clinical practiceRAVDIN, Peter.European journal of cancer. Supplement (1990). 2006, Vol 4, Num 5, pp 13-17, issn 1359-6349, 5 p.Article

Prognosis of patients with resected non-small cell lung cancer : Impact of clinical and pathologic variablesRAVDIN, Peter M; DAVIS, Gregory.Lung cancer. 2006, Vol 52, Num 2, pp 207-212, issn 0169-5002, 6 p.Article

Management of Breast Cancer : A New Therapeutic Approach. SymposiumLATREILLE, Jean; RAVDIN, Peter M.Seminars in oncology. 1995, Vol 22, Num 6, issn 0093-7754, 42 p., SUP13Conference Proceedings

The use of HER2 testing in the management of breast cancerRAVDIN, Peter.Seminars in oncology. 2000, Vol 27, Num 5, pp 33-42, issn 0093-7754, SUP9Conference Paper

Docetaxel (Taxotere) : An overview of first-line monotherapyTRUDEAU, M. E.Seminars in oncology. 1995, Vol 22, Num 6, pp 17-21, issn 0093-7754, SUP13Conference Paper

Hormone Replacement Therapy and the Increase in the Incidence of Invasive Lobular CancerRAVDIN, Peter M.Breast disease. 2008, Vol 30, pp 3-8, issn 0888-6008, 6 p.Article

Taxoids : Effective agents in anthracycline-resistant breast cancerRAVDIN, P. M.Seminars in oncology. 1995, Vol 22, Num 6, pp 29-34, issn 0093-7754, SUP13Conference Paper

2000 update of recommendations for the use of tumor markers in breast and colorectal cancer : Clinical practice guidelines of the American Society of Clinical OncologyBAST, Robert C; RAVDIN, Peter; HAYES, Daniel F et al.Journal of clinical oncology. 2001, Vol 19, Num 6, pp 1865-1878, issn 0732-183XArticle

American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast CancerHARRIS, Lyndsay; FRITSCHE, Herbert; MENNEL, Robert et al.Journal of clinical oncology. 2007, Vol 25, Num 33, pp 5287-5312, issn 0732-183X, 26 p.Article

Overview of randomized trials of systemic adjuvant therapyRAVDIN, Peter M.Cancer treatment and research. 2000, Vol 103, pp 157-181, issn 0927-3042Article

Choosing between endocrine therapy and chemotherapy - or is there a role for combination therapy?FORBES, John F; GRADISHAR, William J; RAVDIN, Peter M et al.Breast cancer research and treatment. 2002, Vol 75, pp S37-S44, issn 0167-6806, SUP1Article

Docetaxel (Taxotere) : An effective agent in the management of second-line breast cancerVAN OOSTEROM, A. T.Seminars in oncology. 1995, Vol 22, Num 6, pp 22-28, issn 0093-7754, SUP13Conference Paper

Patterns of Treatment for Early Stage Breast Cancers at the M. D. Anderson Cancer Center From 1997 to 2004YU SHEN; WENLI DONG; FEIG, Barry W et al.Cancer. 2009, Vol 115, Num 10, pp 2041-2051, issn 0008-543X, 11 p.Article

Poor-Prognosis Estrogen Receptor-Positive Breast Cancer Identified by Histopathologic SubclassificationWEBSTER, Lucy R; LEE, Shu-Fen; GREEN, Andrew R et al.Clinical cancer research (Print). 2008, Vol 14, Num 20, pp 6625-6633, issn 1078-0432, 9 p.Article

Docetaxel (Taxotere) in combination : A step forwardBURRIS, H. A; FIELDS, S; PEACOCK, N et al.Seminars in oncology. 1995, Vol 22, Num 6, pp 35-40, issn 0093-7754, SUP13Conference Paper

Preclinical profile of docetaxel (Taxotere) : Efficacy as a single agent and in combinationBISSERY, M.-C; VRIGNAUD, P; LAVELLE, F et al.Seminars in oncology. 1995, Vol 22, Num 6, pp 3-16, issn 0093-7754, SUP13Conference Paper

Prediction Model for Estimating the Survival Benefit of Adjuvant Radiotherapy for Gallbladder CancerWANG, Samuel J; FULLER, C. David; KIM, Jong-Sung et al.Journal of clinical oncology. 2008, Vol 26, Num 13, pp 2112-2117, issn 0732-183X, 6 p.Article

Computer program to assist in making decisions about adjuvant therapy for women with early breast cancerRAVDIN, Peter M; SIMINOFF, Laura A; DAVIS, Greg J et al.Journal of clinical oncology. 2001, Vol 19, Num 4, pp 980-991, issn 0732-183XArticle

The decrease in breast-cancer incidence in 2003 in the United StatesRAVDIN, Peter M; CRONIN, Kathleen A; HOWLADER, Nadia et al.The New England journal of medicine. 2007, Vol 356, Num 16, pp 1670-1674, issn 0028-4793, 5 p.Article

Population-based validation of the prognostic model ADJUVANT! for early breast cancerOLIVOTTO, Ivo A; BAJDIK, Chris D; RAVDIN, Peter M et al.Journal of clinical oncology. 2005, Vol 23, Num 12, pp 2716-2725, issn 0732-183X, 10 p.Article

Randomized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus cyclophosphamide, doxorubicin, and fluorouracil with and without tamoxifen for high-risk, node-negative breast cancer : Treatment results of intergroup protocol INT-0102HUTCHINS, Laura F; GREEN, Stephanie J; RAVDIN, Peter M et al.Journal of clinical oncology. 2005, Vol 23, Num 33, pp 8313-8321, issn 0732-183X, 9 p.Conference Paper

Independent Prognostic Value of Screen Detection in Invasive Breast CancerMOOK, Stella; VAN 'T VEER, Laura J; RUTGERS, Emiel J et al.Journal of the National Cancer Institute. 2011, Vol 103, Num 7, pp 585-597, issn 0027-8874, 13 p.Article

A Southwest Oncology Group randomized phase II study of doxorubicin and paclitaxel as frontline chemotherapy for women with metastatic breast cancerLYMAN, Gary H; GREEN, Stephanie J; RAVDIN, Peter M et al.Breast cancer research and treatment. 2004, Vol 85, Num 2, pp 143-150, issn 0167-6806, 8 p.Article

Prognostic Utility of the 21-Gene Assay in Hormone Receptor-Positive Operable Breast Cancer Compared With Classical Clinicopathologic FeaturesGOLDSTEIN, Lori J; GRAY, Robert; SLEDGE, George W et al.Journal of clinical oncology. 2008, Vol 26, Num 25, pp 4063-4071, issn 0732-183X, 9 p.Article

The EORTC 10041/BIG 03-04 MINDACT trial is feasible: Results of the pilot phaseRUTGERS, Emiel; PICCART-GEBHART, Martine J; VINDEVOGHEL, Anita et al.European journal of cancer (1990). 2011, Vol 47, Num 18, pp 2742-2749, issn 0959-8049, 8 p.Article

  • Page / 2